Cerevance Parkinson’s drug shortens ‘off time’ in Ph. 3, paving path to FDA

The Takeda spinout showed that a high dose of solengepras can shorten the periods during which difficult Parkinson’s disease symptoms like involuntary movements and sleepiness.